Live Breaking News & Updates on Reset Pharmaceuticals

Stay updated with breaking news from Reset pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000

Company may now initiate Phase 2b trial for treatment of demoralization syndrome in patients with cancerNEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health conditions related to life-altering diseases, today announces that the Company has received a Safe to Proceed notification from the U.S. Food and Drug Administration (FDA) regarding its Invest ....

Jan Anders Karlsson , Laurie Doyle , Pharmaceuticals Inc , Filament Health Corp , Drug Administration , Mc Services , Reset Pharma , Investigational New Drug , Reset Pharmaceuticals , Demoralization Syndrome , Scientific Advisory Board , Strategic Advisory Board , Reset Pharmaceutical , Reset Pharma , The Company , Mental Health Conditions , Product Candidate ,

EQS-News: Reset Pharmaceuticals, Inc.: Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000

EQS-News: Reset Pharmaceuticals, Inc.: Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New York , United States , Jan Anders Karlsson , Laurie Doyle , Distribution Services , Mc Services , Drug Administration , Filament Health Corp , Pharmaceuticals Inc , Reset Pharmaceuticals , Pharma Receives Notice , Investigational New Drug , Oral Psilocybin , Reset Pharma , Demoralization Syndrome , Scientific Advisory Board , Strategic Advisory Board , Reset Pharmaceutical , Corporate News , Regulatory Announcements , Ihre Watchlist ,

Filament Health take major step forward entering into licensing agreement with Reset Pharma

  Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to announce a significant licensing agreement between Filament Health and Reset. ....

Ben Lightburn , Drug Administration , Filament Health , Health Canada , Steve Darling , Reset Pharmaceuticals , Reset Pharma ,